BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34857793)

  • 1. Spatial variation of perfusion MRI reflects cognitive decline in mild cognitive impairment and early dementia.
    Morgan CA; Melzer TR; Roberts RP; Wiebels K; Mutsaerts HJMM; Spriggs MJ; Dalrymple-Alford JC; Anderson TJ; Cutfield NJ; Deib G; Pfeuffer J; Addis DR; Kirk IJ; Tippett LJ
    Sci Rep; 2021 Dec; 11(1):23325. PubMed ID: 34857793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classifying cognitive impairment based on the spatial heterogeneity of cerebral blood flow images.
    Shirzadi Z; Stefanovic B; Mutsaerts HJMM; Masellis M; MacIntosh BJ;
    J Magn Reson Imaging; 2019 Sep; 50(3):858-867. PubMed ID: 30666734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of cerebral hyperperfusion in Alzheimer's disease and amnestic mild cognitive impairment using voxel-based analysis of 3D arterial spin-labeling imaging: initial experience.
    Ding B; Ling HW; Zhang Y; Huang J; Zhang H; Wang T; Yan FH
    Clin Interv Aging; 2014; 9():493-500. PubMed ID: 24707173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of Intracranial Stenosis on Cerebral Perfusion and Cognitive Performance.
    Hilal S; Mutsaerts HJMM; Ferro DA; Petr J; Kuijf HJ; Biessels GJ; Chen C
    J Alzheimers Dis; 2021; 79(3):1369-1380. PubMed ID: 33427743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional hyperperfusion in older adults with objectively-defined subtle cognitive decline.
    Thomas KR; Osuna JR; Weigand AJ; Edmonds EC; Clark AL; Holmqvist S; Cota IH; Wierenga CE; Bondi MW; Bangen KJ;
    J Cereb Blood Flow Metab; 2021 May; 41(5):1001-1012. PubMed ID: 32615887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A brain stress test: Cerebral perfusion during memory encoding in mild cognitive impairment.
    Xie L; Dolui S; Das SR; Stockbower GE; Daffner M; Rao H; Yushkevich PA; Detre JA; Wolk DA
    Neuroimage Clin; 2016; 11():388-397. PubMed ID: 27222794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired cerebral blood flow in type 2 diabetes mellitus - A comparative study with subjective cognitive decline, vascular dementia and Alzheimer's disease subjects.
    Chau ACM; Cheung EYW; Chan KH; Chow WS; Shea YF; Chiu PKC; Mak HKF
    Neuroimage Clin; 2020; 27():102302. PubMed ID: 32521474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of Alzheimer's Disease from Frontotemporal Dementia and Mild Cognitive Impairment Based on Arterial Spin Labeling Magnetic Resonance Imaging: A Pilot Cross-Sectional Study from PUMCH Dementia Cohort.
    Mao C; You H; Hou B; Chu S; Jin W; Huang X; Shang L; Feng F; Peng B; Gao J
    J Alzheimers Dis; 2023; 93(2):509-519. PubMed ID: 37038812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between Cerebral Perfusion on Arterial Spin Labeling (ASL) MRI with Brain Volumetry and Cognitive Performance in Mild Cognitive Impairment and Dementia due to Alzheimer's Disease.
    Soman S; Raghavan S; Rajesh PG; Varma RP; Mohanan N; Ramachandran SS; Thomas B; Kesavadas C; Menon RN
    Ann Indian Acad Neurol; 2021; 24(4):559-565. PubMed ID: 34728951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Arterial Spin Labeling Parameters With Cognitive Decline, Vascular Events, and Mortality in a Memory-Clinic Sample.
    Gyanwali B; Mutsaerts HJ; Tan CS; Kaweilh OR; Petr J; Chen C; Hilal S
    Am J Geriatr Psychiatry; 2022 Dec; 30(12):1298-1309. PubMed ID: 35871110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity.
    Binnewijzend MA; Kuijer JP; Benedictus MR; van der Flier WM; Wink AM; Wattjes MP; van Berckel BN; Scheltens P; Barkhof F
    Radiology; 2013 Apr; 267(1):221-30. PubMed ID: 23238159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of changed regional cerebral blood flow in mild cognitive impairment and early Alzheimer's dementia by perfusion-weighted magnetic resonance imaging.
    Luckhaus C; Flüß MO; Wittsack HJ; Grass-Kapanke B; Jänner M; Khalili-Amiri R; Friedrich W; Supprian T; Gaebel W; Mödder U; Cohnen M
    Neuroimage; 2008 Apr; 40(2):495-503. PubMed ID: 18207425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment.
    Mattsson N; Tosun D; Insel PS; Simonson A; Jack CR; Beckett LA; Donohue M; Jagust W; Schuff N; Weiner MW;
    Brain; 2014 May; 137(Pt 5):1550-61. PubMed ID: 24625697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidelay multiparametric arterial spin labeling perfusion MRI and mild cognitive impairment in early stage Parkinson's disease.
    Suo X; Lei D; Cheng L; Li N; Zuo P; Wang DJJ; Huang X; Lui S; Kemp GJ; Peng R; Gong Q
    Hum Brain Mapp; 2019 Mar; 40(4):1317-1327. PubMed ID: 30548099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypo- and hyper-perfusion in MCI and AD identified by different ASL MRI sequences.
    Camargo A; Wang Z;
    Brain Imaging Behav; 2023 Jun; 17(3):306-319. PubMed ID: 36973476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microvascular perfusion based on arterial spin labeled perfusion MRI as a measure of vascular risk in Alzheimer's disease.
    Zhang Q; Stafford RB; Wang Z; Arnold SE; Wolk DA; Detre JA
    J Alzheimers Dis; 2012; 32(3):677-87. PubMed ID: 22886015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial coefficient of variation applied to arterial spin labeling MRI may contribute to predict surgical revascularization outcomes in pediatric moyamoya vasculopathy.
    Tortora D; Scavetta C; Rebella G; Bertamino M; Scala M; Giacomini T; Morana G; Pavanello M; Rossi A; Severino M
    Neuroradiology; 2020 Aug; 62(8):1003-1015. PubMed ID: 32415392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral Blood Flow Predicts Conversion of Mild Cognitive Impairment into Alzheimer's Disease and Cognitive Decline: An Arterial Spin Labeling Follow-up Study.
    Duan W; Zhou GD; Balachandrasekaran A; Bhumkar AB; Boraste PB; Becker JT; Kuller LH; Lopez OL; Gach HM; Dai W
    J Alzheimers Dis; 2021; 82(1):293-305. PubMed ID: 34024834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability of two-dimensional and three-dimensional pseudo-continuous arterial spin labeling perfusion MRI in elderly populations: comparison with 15O-water positron emission tomography.
    Kilroy E; Apostolova L; Liu C; Yan L; Ringman J; Wang DJ
    J Magn Reson Imaging; 2014 Apr; 39(4):931-9. PubMed ID: 24038544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.